Factors involved in deciding to start preventive treatment: qualitative study of clinicians' and lay people's attitudes

作者: David K Lewis , Jude Robinson , Ewan Wilkinson

DOI: 10.1136/BMJ.327.7419.841

关键词:

摘要: Objectives To explore the views of clinicians and lay people about minimum benefit needed to justify drug treatment prevent heart attacks, rationale behind decisions. Design Qualitative study using semi-structured interviews. Participants 4 general practitioners, practice nurses, 18 people. Setting 8 practices 6 community settings across Liverpool. Results Participants varied widely in acceptable benefits chosen. Most found concepts difficult initially, few appreciated that increased length should increase absolute benefits. Lay usually wanted make decisions for themselves, supported this. consider adverse effects costs treatment. Dislike taking was common, many preferred lifestyle change an imperfect Quality life personal were more important than individual's age. Conclusions Evidence based guidelines assumptions people's preferences, and, by 10 year estimates risk, inflate apparent It is unlikely could incorporate wide range true dialogue necessary between patients before starting long term preventive

参考文章(25)
Andreas Laupacis, Steven A. Grover, Annette M. O'Connor, George Wells, Finlay A. McAlister, When should hypertension be treated? The different perspectives of Canadian family physicians and patients Canadian Medical Association Journal. ,vol. 163, pp. 403- 408 ,(2000)
Karin I. Kjellgren, Johan Ahlner, Roger Säljö, Taking antihypertensive medication — controlling or co-operating with patients? International Journal of Cardiology. ,vol. 47, pp. 257- 268 ,(1995) , 10.1016/0167-5273(94)02203-U
Staffan Svensson, Karin I Kjellgren, Johan Ahlner, Roger Säljö, Reasons for adherence with antihypertensive medication. International Journal of Cardiology. ,vol. 76, pp. 157- 163 ,(2000) , 10.1016/S0167-5273(00)00374-0
N. Barber, What constitutes good prescribing BMJ. ,vol. 310, pp. 923- 925 ,(1995) , 10.1136/BMJ.310.6984.923
Michael H. Alderman, Bernard Lamport, Labelling of hypertensives: a review of the data. Journal of Clinical Epidemiology. ,vol. 43, pp. 195- 200 ,(1990) , 10.1016/0895-4356(90)90185-R
Paul Atkinson, Amanda Coffey, Making sense of qualitative data ,(1996)
Lachlan Forrow, Science, Ethics, and the Making of Clinical Decisions JAMA. ,vol. 259, pp. 3161- 3167 ,(1988) , 10.1001/JAMA.1988.03720210051029